Inmunoterapia para el cáncer de mama en China — obtén 3 clínicas con costos

Immunotherapy for breast cancer in China typically costs from $22,500 to $82,000. The final price depends on the drug origin, hospital tier, and required cycles. Patients save approximately 25% compared to the US, where costs average $70,000. Standard inclusions often cover the medication, basic diagnostics, and specialist consultations in major medical hubs like Guangzhou, Shanghai, and Beijing.

• Domestic PD-1 inhibitors: Often 60-80% cheaper than imported brands due to national drug list inclusions.
• Imported immunotherapy drugs: Typically cost 25-35% more than local alternatives at specialized international clinics.
• Hospital tier levels: Private international facilities often charge higher premiums than public Level-3A hospitals.
• Ancillary diagnostics: Specialized PD-L1 testing and PET-CT scans add to the base treatment price.

Bookimed Expert Insight: Choosing specialized centers like Fuda Cancer Hospital provides access to JCI-accredited care. This facility has treated over 30,000 international patients using advanced cryosurgery and immunotherapy. Combining these minimally invasive therapies often yields better results for late-stage cases. While public hospitals are cheaper, private centers offer dedicated international departments. This ensures seamless communication and faster access to newest drug protocols.